Joint Ventures3 April 2026 at 02:31 pm
Senores Pharmaceuticals Enters Strategic Joint Venture in the US for Federal and Defense Sector Supplies
AI Summary
Senores Pharmaceuticals Limited has announced a strategic joint venture through its US subsidiary, Senores Pharmaceuticals, Inc. The joint venture, named Amerisyn, LLC, will enable Senores to supply its high-quality product portfolio to the U.S. Federal Government, veterans affairs and military supply contracts. This partnership is expected to be a significant driver of growth and a substantial contributor to Senores' international business volumes.
Key Highlights
- Senores Pharmaceuticals enters a strategic joint venture in the US through its subsidiary, Senores Pharmaceuticals, Inc.
- The joint venture, named Amerisyn, LLC, will facilitate the supply of Senores' products to the U.S. Federal Government, veterans affairs and military supply contracts.
- This partnership is expected to contribute significantly to Senores' international business volumes.
- Senores Pharmaceuticals Limited is a global, research-driven pharmaceutical company with a wide range of products and a strong presence in the US, Canada, and other regulated and emerging markets.
- Senores has strong R&D capabilities and manufactures critical care injectables and Active Pharmaceutical Ingredients (API).